Dr. Ramona Meanti is a post-doc at University of Milano-Bicocca, Italy. She received her PhD degree in Experimental Neuroscience from the University in Milano-Bicocca in 2022, working since 2018 in the field of pharmacology. Her research interests include the characterization of neuroprotective activities of growth hormone secretagogues in different neurodegenerative diseases (amyotrophic lateral sclerosis and multiple sclerosis) and their implication in the modulation of oxidative stress and apoptosis pathway. She is a member of Italian Society of Pharmacology (SIF), of the Milan Center for Neuroscience (NeuroMI), of the Italian Association of Miology (AIM) and of Italian Society for Neuroscience (SINS).
Dr. Ramona Meanti is a post-doc at University of Milano-Bicocca, Italy. She received her PhD degree in Experimental Neuroscience from the University in Milano-Bicocca in 2022, working since 2018 in the field of pharmacology. Her research interests include the characterization of neuroprotective activities of growth hormone secretagogues in different neurodegenerative diseases (amyotrophic lateral sclerosis and multiple sclerosis) and their implication in the modulation of oxidative stress and apoptosis pathway. She is a member of Italian Society of Pharmacology (SIF), of the Milan Center for Neuroscience (NeuroMI), of the Italian Association of Miology (AIM) and of Italian Society for Neuroscience (SINS).